Skip to main content

trans-Ned-19

ALX-270-503

28 citations

  • ALX-270-503-MC05   —   0.5 mg
    $285.00
  • ALX-270-503-M001   —   1 mg
    $443.00

Cell permeable, selective and potent inhibitor of nicotinic acid adenine dinucleotide phosphate (NAADP) receptor in mammalian cells and sea urchin eggs. Blocks NAADP signaling. Inhibits Ca2+ release: trans-Ned-19 (IC50 = 6nM); cis-Ned-19 (IC50 = 800nM). [32P] NAADP binding: trans-Ned-19 (IC50 = 0.4nM); cis-Ned-19 (IC50 = 15µM).Inhibits Ca2+ release from lysosomes. Noncompetitive antagonist. Fluorescent.

NAADP (nicotinic acid adenine dinucleotide phosphate) is an emerging Ca2+ releasing second messenger in several mammalian tissues including pancreatic, brain and cardiac tissue.

Shipping: Available products typically ship within 24/48h, via priority shipping.

Do you need support? Contact Customer Service or Technical Support.

Online Account
Access or Create Your Account


Regulatory Status

RUO – Research Use Only